Evidence map›Paper›PMID 39695787›Full record

ArticleBiological research2024

Lack of canonical activities of connexins in highly aggressive human prostate cancer cells.

Catalina Asencio, Loreto Véliz, Emilia Flores-Faúndez, Lorena Azócar, Carolina E Echeverría, Verónica Torres-Estay, Viviana Orellana, Catalina Ramírez-Santelices, Paula Sotomayor, Jorge Cancino and 5 more

Abstract read
In one paragraph

Article in Biological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Beyond the gap: moonlighting functions of connexins in cancer.Cell communication and signaling : CCS · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Catalina Asencio *Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
Loreto Véliz *Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.
Emilia Flores-FaúndezCentro de Biología Celular y Biomedicina CEBICEM, Facultad de Medicina y Ciencia, Universidad San Sebastián, Lota 2465, Providencia., Santiago, 7510156, Chile.
Lorena AzócarCentro de Biología Celular y Biomedicina CEBICEM, Facultad de Medicina y Ciencia, Universidad San Sebastián, Lota 2465, Providencia., Santiago, 7510156, Chile.
Carolina E EcheverríaDepartment of Medicine, NYU Grossman School of Medicine, New York, NY, USA.
Verónica Torres-EstayEscuela de Química y Farmacia, Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago, Chile.
Viviana OrellanaPrograma de Comunicación Celular en Cáncer, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, 7610634, Chile.
Catalina Ramírez-SantelicesCentro de Biología Celular y Biomedicina CEBICEM, Facultad de Medicina y Ciencia, Universidad San Sebastián, Lota 2465, Providencia., Santiago, 7510156, Chile.
Paula SotomayorDepartment of Urology, Pontificia Universidad Católica de Chile, Santiago, Chile.
Jorge CancinoCentro de Biología Celular y Biomedicina CEBICEM, Facultad de Medicina y Ciencia, Universidad San Sebastián, Lota 2465, Providencia., Santiago, 7510156, Chile.
Bredford KerrCentro de Biología Celular y Biomedicina CEBICEM, Facultad de Medicina y Ciencia, Universidad San Sebastián, Lota 2465, Providencia., Santiago, 7510156, Chile.
Ainoa Fernandez-OlivaresPrograma de Comunicación Celular en Cáncer, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, 7610634, Chile.
Mauricio A RetamalPrograma de Comunicación Celular en Cáncer, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, 7610634, Chile.
Juan C SáezCentro Interdisciplinario de Neurociencias de Valparaíso, Instituto de Neurociencia, Universidad de Valparaíso, Valparaíso, Chile.
Alejandro S GodoyCentro de Biología Celular y Biomedicina CEBICEM, Facultad de Medicina y Ciencia, Universidad San Sebastián, Lota 2465, Providencia., Santiago, 7510156, Chile. alejandro.godoy@uss.cl.ORCID http://orcid.org/0000-0002-8208-023X

Funding

FONDECYT Regular 1221067ICM-ANID P09-022
6 · The paper itself

Abstract

Connexins (Cxs) have the ability to form channels that allow the exchange of ions/metabolites between adjacent cells (gap junction channels, GJC) or between the intra- and extra-cellular compartments (hemichannels, HC). Cxs were initially classified as tumor suppressors. However, more recently, it has been shown that Cxs exert anti- and pro-tumorigenic effects depending on the cell and tissue context. In prostate cancer (PCa), the expression and functionality of Cxs remain highly controversial. Here, we analyzed the expression pattern of Cx26, Cx32, Cx37, Cx40, Cx43 and Cx45 in PCa cell lines with increasing levels of tumor aggressiveness (LNCaP < LNCaP-C4-2 < Du-145 < PC-3). In addition, GJ and HC activities were evaluated in the PCa cell lines using dye coupling and dye uptake assays, respectively. Lastly, the cellular localization of Cx26, Cx32, and Cx43 was analyzed in LNCaP and PC-3 cell lines using immunofluorescence analyses. Our results showed a positive association between the mRNA levels of Cx26, Cx37 and Cx45 and the degree of aggressiveness of PCa cells, a negative association in the case of Cx32 and Cx43, and no clear pattern for Cx40. At the protein level, a negative relationship between the expression of Cx26, Cx32 and Cx43 and the degree of aggressiveness of PCa cell lines was observed. No significant differences were observed for the expression of Cx37, Cx40, and Cx45 in PCa cell lines. At the functional level, only LNCaP cells showed moderate GJ activity and LNCaP and LNCaP-C4-2 cells showed HC activity. Immunofluorescence analyses confirmed that the majority of Cx26, Cx32, and Cx43 expression was localized in the cytoplasm of both LNCaP and PC3 cell lines. This data indicated that GJ and HC activities were moderately detected only in the less aggressive PCa cells, which suggest that Cxs expression in highly aggressive PCa cells could be associated to channel-independent roles.

Indexed as

ConnexinsProstatic NeoplasmsCell Line, TumorConnexin 26Gap JunctionsHumansMaleConnexin 26ConnexinsConnexinsGap junctionsHemichannelsProstate cancer

Identifiers

PMID39695787
PMCPMC11658540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.